Industry Experts

Remi Laberge PhD is a cellular biologist focusing on translational research in chronic diseases, oncology, and targeted therapeutics.  He is the co-founder and chief technology officer of Arda Therapeutics, a company developing pathogenic cell depleters as therapy for chronic diseases.  Dr. Laberge uses cutting edge technologies to bridge preclinical discovery and clinical application.  Dr. Laberge has led several interdisciplinary drug discovery projects developing biologics, including antibody-drug conjugates, and small molecules.